MiRagen Therapeutics Lands $7,000,000 Series B Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=024b30d8-ead8-48bb-8f40-8349b54c3eb5
Date
7/1/2014
Company Name
MiRagen Therapeutics
Mailing Address
6200 Lookout Rd Boulder, CO 80301 USA
Company Description
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Website
http://www.miragentherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$7,000,000
Transaction Round
Series B
Proceeds Purposes
Leverone said the extension with Servier is independent of the latest Series B funding installment. That money, he said, will be used to advance MiRagen assets that are not part of the Servier deal.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor